ArticlePloS one2013

Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling.

Sherif A Ibrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.